Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

As part of the deal, which could be worth $3.5bn, BMS will gain developmental support and therapeutic reagents from Prime ...

GlobalData’s report assesses the drugs in the Insulin Like Growth Factor I pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Metabotropic Glutamate Receptor 7 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Plasma Kallikrein  pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Hepcidin pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Estrogen Receptor Beta pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Cell Division Cycle 7 Related Protein Kinase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the ...

GlobalData’s report assesses the drugs in the Alpha L-Iduronidase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Fibroblast Growth Factor 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Alpha N-Acetylglucosaminidase pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

GlobalData’s report assesses the drugs in the Toll Like Receptor 3 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.